Bavarian Nordic Company

Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.
Technology:
Viral Vectors
Industry:
Viral Vectors
Headquarters:
Kvistgaard, Hovedstaden, Denmark
Founded Date:
1994-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
1
Total Funding:
60000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2016-04-13
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership